Skip to content

Clinical trials

Lymphoma, B-Cell, Marginal Zone trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Country / region: South Korea Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20092
20111
20133
20141
20151
20163
20181
20195
20201
20214
20222
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated8
Active, not recruiting4
Recruiting4
Unknown status3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center4
Seoul National University Hospital3
BeOne Medicines2
Dong-A University Hospital2
Gilead Sciences2
MEI Pharma, Inc.2
Regeneron Pharmaceuticals2
AstraZeneca1
BeiGene1
Boryung Pharmaceutical Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone32
Lymphoma, Follicular22
Leukemia, Lymphocytic, Chronic, B-Cell13
Lymphoma, Mantle-Cell13
Lymphoma, Non-Hodgkin13
Lymphoma, Large B-Cell, Diffuse11
Waldenstrom Macroglobulinemia11
Recurrence8
Lymphoma, B-Cell7
Burkitt Lymphoma4

Trials

Showing 51 to 32 of 32. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.